| Clonal hematopoiesis and risk of atherosclerotic cardiovascular disease S Jaiswal, P Natarajan, AJ Silver, CJ Gibson, AG Bick, E Shvartz, ... New England Journal of Medicine 377 (2), 111-121, 2017 | 2273 | 2017 |
| Genetic risk, adherence to a healthy lifestyle, and coronary disease AV Khera, CA Emdin, I Drake, P Natarajan, AG Bick, NR Cook, ... New England Journal of Medicine 375 (24), 2349-2358, 2016 | 1441 | 2016 |
| Ticagrelor with or without aspirin in high-risk patients after PCI R Mehran, U Baber, SK Sharma, DJ Cohen, DJ Angiolillo, C Briguori, ... New England Journal of Medicine 381 (21), 2032-2042, 2019 | 916 | 2019 |
| Cessation of dual antiplatelet treatment and cardiac events after percutaneous coronary intervention (PARIS): 2 year results from a prospective observational study R Mehran, U Baber, PG Steg, C Ariti, G Weisz, B Witzenbichler, TD Henry, ... The Lancet 382 (9906), 1714-1722, 2013 | 690 | 2013 |
| Comparison of propensity score methods and covariate adjustment: evaluation in 4 cardiovascular studies MC Elze, J Gregson, U Baber, E Williamson, S Sartori, R Mehran, ... Journal of the American College of Cardiology 69 (3), 345-357, 2017 | 678 | 2017 |
| Exome-wide association study of plasma lipids in> 300,000 individuals DJ Liu, GM Peloso, H Yu, AS Butterworth, X Wang, A Mahajan, ... Nature genetics 49 (12), 1758-1766, 2017 | 567 | 2017 |
| Polygenic risk score identifies subgroup with higher burden of atherosclerosis and greater relative benefit from statin therapy in the primary prevention setting P Natarajan, R Young, NO Stitziel, S Padmanabhan, U Baber, R Mehran, ... Circulation 135 (22), 2091-2101, 2017 | 543 | 2017 |
| Coronary thrombosis and major bleeding after PCI with drug-eluting stents: risk scores from PARIS U Baber, R Mehran, G Giustino, DJ Cohen, TD Henry, S Sartori, C Ariti, ... Journal of the American College of Cardiology 67 (19), 2224-2234, 2016 | 534 | 2016 |
| Prevalence, impact, and predictive value of detecting subclinical coronary and carotid atherosclerosis in asymptomatic adults: the BioImage study U Baber, R Mehran, S Sartori, MM Schoos, H Sillesen, P Muntendam, ... Journal of the American College of Cardiology 65 (11), 1065-1074, 2015 | 519 | 2015 |
| Duration of dual antiplatelet therapy after drug-eluting stent implantation: a systematic review and meta-analysis of randomized controlled trials G Giustino, U Baber, S Sartori, R Mehran, I Mastoris, AS Kini, SK Sharma, ... Journal of the American College of Cardiology 65 (13), 1298-1310, 2015 | 403 | 2015 |
| Association of chronic kidney disease with atrial fibrillation among adults in the United States: REasons for Geographic and Racial Differences in Stroke (REGARDS) Study U Baber, VJ Howard, JL Halperin, EZ Soliman, X Zhang, W McClellan, ... Circulation: Arrhythmia and Electrophysiology 4 (1), 26-32, 2011 | 350 | 2011 |
| Machine learning prediction in cardiovascular diseases: a meta-analysis C Krittanawong, HUH Virk, S Bangalore, Z Wang, KW Johnson, R Pinotti, ... Scientific reports 10 (1), 16057, 2020 | 347 | 2020 |
| Impact of the everolimus-eluting stent on stent thrombosis: a meta-analysis of 13 randomized trials U Baber, R Mehran, SK Sharma, S Brar, J Yu, JW Suh, HS Kim, SJ Park, ... Journal of the American College of Cardiology 58 (15), 1569-1577, 2011 | 330 | 2011 |
| Deep learning for cardiovascular medicine: a practical primer C Krittanawong, KW Johnson, RS Rosenson, Z Wang, M Aydar, U Baber, ... European heart journal 40 (25), 2058-2073, 2019 | 328 | 2019 |
| Changes in plaque lipid content after short-term intensive versus standard statin therapy: the YELLOW trial (reduction in yellow plaque by aggressive lipid-lowering therapy) AS Kini, U Baber, JC Kovacic, A Limaye, ZA Ali, J Sweeny, A Maehara, ... Journal of the American College of Cardiology 62 (1), 21-29, 2013 | 300 | 2013 |
| Duration of dual antiplatelet therapy: a systematic review for the 2016 ACC/AHA guideline focused update on duration of dual antiplatelet therapy in patients with coronary … JA Bittl, U Baber, SM Bradley, DN Wijeysundera Journal of the American College of Cardiology 68 (10), 1116-1139, 2016 | 287 | 2016 |
| Aspirin-free strategies in cardiovascular disease and cardioembolic stroke prevention D Capodanno, R Mehran, M Valgimigli, U Baber, S Windecker, P Vranckx, ... Nature Reviews Cardiology 15 (8), 480-496, 2018 | 217 | 2018 |
| Edoxaban versus vitamin K antagonist for atrial fibrillation after TAVR NM Van Mieghem, M Unverdorben, C Hengstenberg, H Moellmann, ... New England Journal of Medicine 385 (23), 2150-2160, 2021 | 215 | 2021 |
| P2Y12 inhibitor monotherapy or dual antiplatelet therapy after coronary revascularisation: individual patient level meta-analysis of randomised controlled trials M Valgimigli, F Gragnano, M Branca, A Franzone, U Baber, Y Jang, ... Bmj 373, 2021 | 205 | 2021 |
| Sex-based differences in outcomes with transcatheter aortic valve therapy: TVT registry from 2011 to 2014 J Chandrasekhar, G Dangas, J Yu, S Vemulapalli, S Suchindran, AN Vora, ... Journal of the American College of Cardiology 68 (25), 2733-2744, 2016 | 204 | 2016 |
